180 related articles for article (PubMed ID: 9488199)
1. Vascular smooth muscle cell migration, atherosclerosis, and calcium channel blockers.
Schachter M
Int J Cardiol; 1997 Dec; 62 Suppl 2():S85-90. PubMed ID: 9488199
[TBL] [Abstract][Full Text] [Related]
2. Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein--proteoglycan interaction.
Vijayagopal P; Subramaniam P
Atherosclerosis; 2001 Aug; 157(2):353-60. PubMed ID: 11472734
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?
Tulenko TN; Laury-Kleintop L; Walter MF; Mason RP
Int J Cardiol; 1997 Dec; 62 Suppl 2():S55-66. PubMed ID: 9488196
[TBL] [Abstract][Full Text] [Related]
4. Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells.
Patel MK; Clunn GF; Lymn JS; Austin O; Hughes AD
Br J Pharmacol; 2005 Jul; 145(6):811-7. PubMed ID: 15880143
[TBL] [Abstract][Full Text] [Related]
5. Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation.
Stepien O; Gogusev J; Zhu DL; Iouzalen L; Herembert T; Drueke TB; Marche P
J Cardiovasc Pharmacol; 1998 May; 31(5):786-93. PubMed ID: 9593080
[TBL] [Abstract][Full Text] [Related]
6. [Calcium antagonists decrease migration and proliferation activity of human plaque monocytes].
Heimerl J; Höfling B; Heidemann P; Emberger C; Kandolf R; Bauriedel G
Vasa Suppl; 1992; 35():134-6. PubMed ID: 1481018
[No Abstract] [Full Text] [Related]
7. Amlodipine and vascular hypertrophy.
Stepien O; Iouzalen L; Herembert T; Zhu DL; Marche P
Int J Cardiol; 1997 Dec; 62 Suppl 2():S79-84. PubMed ID: 9488198
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists and vascular smooth muscle cell reactivity.
Marche P; Stepien O
Z Kardiol; 2000; 89 Suppl 2():140-4. PubMed ID: 10769418
[TBL] [Abstract][Full Text] [Related]
9. Smooth muscle cell response to mechanical injury involves intracellular calcium release and ERK1/ERK2 phosphorylation.
Moses S; Dreja K; Lindqvist A; Lövdahl C; Hellstrand P; Hultgårdh-Nilsson A
Exp Cell Res; 2001 Sep; 269(1):88-96. PubMed ID: 11525642
[TBL] [Abstract][Full Text] [Related]
10. Effects of amlodipine on gene expression and extracellular matrix formation in human vascular smooth muscle cells and fibroblasts: implications for vascular protection.
Eickelberg O; Roth M; Block LH
Int J Cardiol; 1997 Dec; 62 Suppl 2():S31-7. PubMed ID: 9488193
[TBL] [Abstract][Full Text] [Related]
11. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes.
Corsini A; Bonfatti M; Quarato P; Accomazzo MR; Raiteri M; Sartani A; Testa R; Nicosia S; Paoletti R; Fumagalli R
J Cardiovasc Pharmacol; 1996 Nov; 28(5):687-94. PubMed ID: 8945683
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium channel blockers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses.
Munro E; Patel M; Chan P; Betteridge L; Gallagher K; Schachter M; Wolfe J; Sever P
J Cardiovasc Pharmacol; 1994 May; 23(5):779-84. PubMed ID: 7521461
[TBL] [Abstract][Full Text] [Related]
13. [Amlodipine and the mechanisms of vascular hypertrophy].
Marche P
Drugs; 2000; 59 Spec No 2():1-7. PubMed ID: 11002853
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blockers reduce blood pressure in part by inhibiting vascular smooth muscle carbonic anhydrase I.
Puscas L; Gilau L; Coltau M; Pasca R; Domuta G; Baican M; Hecht A
Cardiovasc Drugs Ther; 2000 Oct; 14(5):523-8. PubMed ID: 11101200
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel blockers and atherosclerosis.
Sowers JR
Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):3-9. PubMed ID: 2220798
[TBL] [Abstract][Full Text] [Related]
16. Calcium antagonists and atherosclerosis.
Schachter M
Int J Cardiol; 1997 Dec; 62 Suppl 2():S9-15. PubMed ID: 9488190
[TBL] [Abstract][Full Text] [Related]
17. Dual mechanism of action of amlodipine in human vascular smooth muscle cells.
Stepien O; Zhang Y; Zhu D; Marche P
J Hypertens; 2002 Jan; 20(1):95-102. PubMed ID: 11791031
[TBL] [Abstract][Full Text] [Related]
18. Molecular pharmacology of UK-118, 434-05, a permanently charged amlodipine analog.
Heath B; Xia J; Kass RS
Int J Cardiol; 1997 Dec; 62 Suppl 2():S47-54. PubMed ID: 9488195
[TBL] [Abstract][Full Text] [Related]
19. [Effects of angiotensin II receptor blockers, angiotensin converting enzyme inhibitors, 3-hydroxy-3-methyl glutaryl (HMG) CoA reductase inhibitors, amlodipine and epalrestat on cultured basilar artery smooth muscle cell proliferation].
Yamaguchi T; Ida T; Hiraga M; Oishi K; Uchida MK; Echizen H
Yakugaku Zasshi; 2004 Mar; 124(3):159-63. PubMed ID: 15049134
[TBL] [Abstract][Full Text] [Related]
20. Effect of amlodipine on the growth of vascular smooth muscle cells of spontaneously hypertensive rats.
Tang J; Liu Z; Ren D; Wu C
J Tongji Med Univ; 1997; 17(3):165-7. PubMed ID: 9812770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
